昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06127 昭衍新药

已收盘 04-08 16:08:19

21.220

+0.000

0.00%

最高21.760	最低20.400	成交量402.71万
今开21.220	昨收21.220	日振幅6.41%
总市值158.94亿	流通市值25.25亿	总股本7.49亿
成交额8,474万	换手率3.38%	流通股本1.19亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06127","market":"HK","secType":"STK","nameCN":"昭衍新药","latestPrice":21.22,"timestamp":1775635699006,"preClose":21.22,"halted":0,"volume":4027121,"delay":0,"changeRate":0,"floatShares":118995206,"shares":749000000,"eps":0.1,"marketStatus":"已收盘","change":0,"latestTime":"04-08 16:08:19","open":21.22,"high":21.76,"low":20.4,"amount":84742898,"amplitude":0.06409,"askPrice":21.22,"askSize":300,"bidPrice":21.18,"bidSize":7100,"shortable":3,"etf":0,"ttmEps":0.44,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1775698200000},"marketStatusCode":5,"adr":0,"listingDate":1614268800000,"exchange":"SEHK","adjPreClose":21.22,"dividendRate":0.001601,"openAndCloseTimeList":[[1775611800000,1775620800000],[1775624400000,1775635200000]],"volumeRatio":0.341088,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"603127","market":"SH","secType":"STK","nameCN":"昭衍新药","latestPrice":35.95,"timestamp":1775631600000,"preClose":35.57,"halted":0,"volume":36456600,"delay":0,"premium":"-48.57"}},"requestUrl":"/m/hq/s/06127","defaultTab":"news","newsList":[{"id":"1129609904","title":"昭衍新药3月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1129609904","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129609904?lang=zh_cn&edition=full","pubTime":"2026-04-08 16:25","pubTimestamp":1775636753,"startTime":"0","endTime":"0","summary":"2026年4月8日，北京昭衍新药研究中心股份有限公司披露2026年3月股份变动月报表，报告期截至2026年3月31日。公告显示，公司H股与A股合并计算的已发行股本保持不变。报告期内，公司已发行H股数量为118,995,206股，与上月一致；A股已发行数量为630,353,014股，同样未发生变化。其中，A股库存股份数量为3,173,920股，与上月相同，报告期内无新增发行、回购或注销安排。公司指出，截至3月底，各类股本结构与数量仍维持稳定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624659313","title":"昭衍新药（603127）披露股票交易异常波动公告，4月3日股价上涨0.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624659313","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624659313?lang=zh_cn&edition=full","pubTime":"2026-04-03 17:24","pubTimestamp":1775208259,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，昭衍新药报收于36.6元，较前一交易日上涨0.41%，最新总市值为274.26亿元。该股当日开盘36.16元，最高37.25元，最低35.03元，成交额达15.89亿元，换手率为6.92%。公司于2026年4月1日披露《股票交易异常波动公告》。公告显示，昭衍新药股票于2026年3月27日、3月30日和3月31日连续3个交易日内收盘价格涨幅偏离值累计超过20%，构成股票交易异常波动。董事会确认无应披露未披露事项。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300034308.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06127","BK0216","BK1141","BK1576","603127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624543215","title":"去年下半年增持昭衍新药、建仓特宝生物 中欧基金葛兰自购旗下独管医药基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2624543215","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624543215?lang=zh_cn&edition=full","pubTime":"2026-04-01 07:27","pubTimestamp":1774999620,"startTime":"0","endTime":"0","summary":"2025年下半年，葛兰旗下3只基金的内部持有情况出现明显分化。3月31日，中欧基金投资总监、明星基金经理葛兰在管的3只公募基金披露2025年报，其隐形重仓股也随之曝光。具体来看，同为医药主题的中欧医疗健康、中欧医疗创新均大幅增持了昭衍新药，同时中欧医疗创新还重新买回了奥浦迈、博腾股份、三生国健，并首次建仓特宝生物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604013690999074.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604013690999074.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0216","688278","BK1141","603127","BK1576","160635","06127","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623079833","title":"昭衍新药：股票交易异常波动","url":"https://stock-news.laohu8.com/highlight/detail?id=2623079833","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623079833?lang=zh_cn&edition=full","pubTime":"2026-03-31 17:35","pubTimestamp":1774949701,"startTime":"0","endTime":"0","summary":"南财智讯3月31日电，昭衍新药公告，公司股票于2026年3月27日、3月30日和3月31日连续3个交易日内收盘价格涨幅偏离值累计超过20%，构成股票交易异常波动。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603313690516776.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1141","06127","603127","BK1576","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623379186","title":"CXO概念股强势 凯莱英(06821)涨13.85% 机构认为CXO基本面拐点已经出现","url":"https://stock-news.laohu8.com/highlight/detail?id=2623379186","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623379186?lang=zh_cn&edition=full","pubTime":"2026-03-31 10:23","pubTimestamp":1774923794,"startTime":"0","endTime":"0","summary":"金吾财讯 | CXO概念股强势，凯莱英(06821)涨13.85%，昭衍新药(06127)涨7.34%，药明生物(02269)涨5.99%，康龙化成(03759)涨4.54%，药明康德(02359)涨4.12%，泰格医药(03347)涨2.89%，金斯瑞生物科技(01548)涨1.09%。浙商医药团队分析指出，在CXO产业持续出清，股价相对低位背景下，看好本土头部CDMO企业和受益国内需求复苏CRO企业底部投资机会。从财务、需求和供给数据分析，该机构认为CXO基本面拐点已经出现，并有望持续复苏。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/YjA5ZTU5M2U3ZjIyNGI4Mzk2MWM1NGUyNWZkZjFmMjE3MzEwNTIzMzcxNTY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YjA5ZTU5M2U3ZjIyNGI4Mzk2MWM1NGUyNWZkZjFmMjE3MzEwNTIzMzcxNTY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1977810","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348825331.USD","BK1521","LU0819121731.USD","LU0823426308.USD","LU0326950275.SGD","LU1880383366.USD","LU1242518857.USD","LU0417516738.SGD","BK1576","LU0856984785.SGD","002821","02269","BK1589","LU0456827905.SGD","LU0516422440.USD","LU0516423091.SGD","HK0000306685.HKD","LU0572944931.SGD","LU3063872942.SGD","LU0039217434.USD","LU0181495838.USD","06821","LU1688375341.USD","LU0320764599.SGD","02359","LU0359201612.USD","LU0588546209.SGD","LU0043850808.USD","CXO","LU2045819591.USD","LU0140636845.USD","HK0000306701.USD","LU0307460666.USD","LU0516422366.SGD","LU0327786744.USD","IE00B0JY6N72.USD","LU0051755006.USD","LU0348735423.USD","03759","03347","LU0516423174.USD","LU0456846285.SGD","01548","06127","LU1328615791.USD","LU0979878070.USD","LU0823426480.USD","LU1046422090.SGD","LU1794554557.SGD","LU0052750758.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109731579","title":"港股异动 | 医药外包概念走强，昭衍新药绩后涨超13%，凯莱英涨超11%","url":"https://stock-news.laohu8.com/highlight/detail?id=1109731579","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109731579?lang=zh_cn&edition=full","pubTime":"2026-03-31 09:51","pubTimestamp":1774921897,"startTime":"0","endTime":"0","summary":"3月31日，医药外包概念走强，$昭衍新药(06127)$涨超13%，$凯莱英(06821)$涨超11%，$康龙化成(03759)$涨超6%，$药明生物(02269)$、$泰格医药(03347)$涨超5%","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"ee4d118e55b1b421073820cd0cff0613","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK4585","09939","LU1328615791.USD","BK0132","BK1191","BK4588","06821","BK0216","06127","BK1574","BK1576","BK1161","BK0239","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102230524","title":"异动解读 | 昭衍新药盘中大涨5.29%，年度净利润飙升302%提振股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1102230524","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102230524?lang=zh_cn&edition=full","pubTime":"2026-03-31 09:42","pubTimestamp":1774921350,"startTime":"0","endTime":"0","summary":"昭衍新药今日盘中股价大幅上涨5.29%，引起了市场的广泛关注。消息面上，公司于近期发布了2025年年度业绩报告。报告显示，尽管营业收入同比有所下降，但归属于公司股东的净利润达到2.98亿元人民币，同比大幅增长302.1%。根据业绩公告，公司2025年扣除非经常性损益后的净利润同比增长高达1221.30%，经营活动产生的现金流量净额也实现了31.17%的同比增长。此外，公司在手订单及新签订单金额均维持在约26亿元人民币的水平，显示了其业务的稳定性。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"ee4d118e55b1b421073820cd0cff0613","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623366376","title":"港股异动 | 昭衍新药(06127)早盘涨超14% 全年纯利同比增超3倍 实验猴涨价贡献近5亿元利润","url":"https://stock-news.laohu8.com/highlight/detail?id=2623366376","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623366376?lang=zh_cn&edition=full","pubTime":"2026-03-31 09:37","pubTimestamp":1774921027,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，昭衍新药(06127)早盘涨超14%，截至发稿，涨14.54%，报22.3港元，成交额7651.06万港元。消息面上，昭衍新药发布年度业绩，2025年，公司实现营业收入16.58亿元，同比下降17.87%；归属于上市公司股东的净利润2.98亿元，同比增长302.08%。另外，公司整体在手订单金额约为26亿元，新签订单金额约为26亿元，同比均有所增长。公告显示，净利润的增长主要源于生物资产公允价值变动带来的收益。期内，生物资产公允价值变动带来净收益4.76亿元。据悉，昭衍新药的生物资产主要是用于非临床项目评价的非人灵长类实验模型，也就是所谓的“实验猴”。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"ee4d118e55b1b421073820cd0cff0613","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1422706.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1576","603127","VXUS","BK4585","BK4588","BK1141","BK0216","06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126996855","title":"昭衍新药将于2026年08月31日派发末期股息每股0.12元","url":"https://stock-news.laohu8.com/highlight/detail?id=1126996855","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126996855?lang=zh_cn&edition=full","pubTime":"2026-03-30 21:16","pubTimestamp":1774876593,"startTime":"0","endTime":"0","summary":"昭衍新药(06127)公告称，公司董事会建议派发截至2025年12月31日止年度之末期现金股息，每股人民币0.12元，具体股东批准日期尚未公布。公司预期在2026年8月31日向合资格股东派发该笔股息。\n公告显示，此次股息将以港币派付给香港登记处登记的股东，最终港币金额及汇率有待公布。除净日、过户文件递交截止时间等具体安排仍有待明确。\n根据公告，公司向名列于H股股东名册的非居民企业股东派发股息时，将按10%税率代扣企业所得税；若为海外个人股东，则暂不代扣个人所得税。公司提醒非居民企业股东可在收取股息后，按相关税务协定申请退税（如适用）。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623191103","title":"昭衍新药最新公告：2025年度净利润2.98亿元同比增长302%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623191103","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623191103?lang=zh_cn&edition=full","pubTime":"2026-03-30 18:39","pubTimestamp":1774867187,"startTime":"0","endTime":"0","summary":"昭衍新药(603127.SH)公告称，公司发布2025年年度报告，实现营业收入16.58亿元，同比下降17.87%；归属于上市公司股东的净利润为2.98亿元，同比增长302.08%。公司拟向全体股东每10股派发现金红利1.2元(含税)。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000028589.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603127","06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623139778","title":"3月30日昭衍新药涨6.15%，中欧医疗创新股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2623139778","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623139778?lang=zh_cn&edition=full","pubTime":"2026-03-30 16:24","pubTimestamp":1774859040,"startTime":"0","endTime":"0","summary":"证券之星消息，3月30日昭衍新药涨6.15%，收盘报32.1元，换手率7.35%，成交量46.32万手，成交额14.67亿元。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共45家，其中持有数量最多的公募基金为中欧基金的中欧医疗创新股票A。中欧医疗创新股票A目前规模为41.8亿元，最新净值1.4332，较上一交易日上涨5.51%，近一年上涨14.2%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000021286.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06127","603127","BK1141","159891","BK1576","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623387155","title":"每周股票复盘：昭衍新药（603127）参投基金出资调整","url":"https://stock-news.laohu8.com/highlight/detail?id=2623387155","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623387155?lang=zh_cn&edition=full","pubTime":"2026-03-29 01:13","pubTimestamp":1774717989,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，昭衍新药报收于30.24元，较上周的28.1元上涨7.62%。本周，昭衍新药3月27日盘中最高价报30.24元。普通合伙人北京崇德英盛投资管理有限公司将其持有的2000万元未实缴出资份额转让，其中500万元转让给中富创业投资（北京）有限公司，500万元转让给左从林，1000万元转让给刘增玉。本次变更后，普通合伙人认缴比例由23.33%降至1.11%。该基金已在中国证券投资基金业协会完成备案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032900000089.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","BK0216","BK1576","06127","603127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184490371","title":"港股异动 | 创新药板块午后拉升，昭衍新药涨超13%，石药集团涨超11%","url":"https://stock-news.laohu8.com/highlight/detail?id=1184490371","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184490371?lang=zh_cn&edition=full","pubTime":"2026-03-27 13:05","pubTimestamp":1774587950,"startTime":"0","endTime":"0","summary":"信达生物涨超7%，君实生物、诺诚健华涨超6%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"9b241a979bfd22b774f426314475f336","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801","09969","01093","06127","01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622086039","title":"股市必读：昭衍新药（603127）今年截至3月26日累计跌幅已超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622086039","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622086039?lang=zh_cn&edition=full","pubTime":"2026-03-27 01:07","pubTimestamp":1774544829,"startTime":"0","endTime":"0","summary":"截至2026年3月26日收盘，昭衍新药报收于27.49元，下跌2.14%，换手率1.86%，成交量11.73万手，成交额3.26亿元。来自资金流向：3月26日主力资金净流出2326.06万元，占总成交额7.14%，散户资金净流入3599.41万元。交易信息汇总股价提醒3月26日昭衍新药收盘报27.49元，跌2.14%，当日成交1172.57万元。根据收盘数据统计，该股当年累计跌幅20.93%。该股最近90天内共有3家机构给出评级，买入评级2家；过去90天内机构目标均价为39.0。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032700002606.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06127","BK0216","603127","BK1576","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622832558","title":"昭衍新药：公司将于3月31日披露财报","url":"https://stock-news.laohu8.com/highlight/detail?id=2622832558","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622832558?lang=zh_cn&edition=full","pubTime":"2026-03-26 15:48","pubTimestamp":1774511307,"startTime":"0","endTime":"0","summary":"每经AI快讯，有投资者在投资者互动平台提问：请问贵司何时出财报？昭衍新药（603127.SH）3月26日在投资者互动平台表示，公司将于3月31日披露。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603263685499439.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603263685499439.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06127","603127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621479693","title":"每周股票复盘：昭衍新药（603127）股东拟减持不超3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2621479693","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621479693?lang=zh_cn&edition=full","pubTime":"2026-03-22 01:54","pubTimestamp":1774115653,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，昭衍新药报收于28.1元，较上周的32.41元下跌13.3%。本周，昭衍新药3月16日盘中最高价报32.86元。公司公告汇总北京昭衍新药研究中心股份有限公司股东顾晓磊及其一致行动人顾美芳合计减持比例由不超过公司总股本的4.1026%调整为不超过3.00%。其中，顾晓磊拟减持不超过15,061,800股，占比不超过2.01%；顾美芳拟减持不超过7,418,400股，占比不超过0.99%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032200000337.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","BK0216","BK1141","06127","603127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620997254","title":"昭衍新药（603127）披露董事会会议安排公告，3月18日股价下跌0.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620997254","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620997254?lang=zh_cn&edition=full","pubTime":"2026-03-18 22:03","pubTimestamp":1773842596,"startTime":"0","endTime":"0","summary":"截至2026年3月18日收盘，昭衍新药报收于29.28元，较前一交易日下跌0.14%，最新总市值为219.41亿元。该股当日开盘28.72元，最高29.89元，最低28.6元，成交额达8.19亿元，换手率为4.48%。近日，昭衍新药发布H股公告，披露公司董事会将于2026年3月30日举行会议，以考虑及通过本集团截至2025年12月31日止的年度业绩，考虑建议派发末期股息（如有），以及处理其他事项。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800040411.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","BK1576","06127","BK1141","603127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620259742","title":"股东清仓减持引发跌停 昭衍新药紧急调整方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2620259742","media":"经济参考网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620259742?lang=zh_cn&edition=full","pubTime":"2026-03-18 21:20","pubTimestamp":1773840000,"startTime":"0","endTime":"0","summary":"3月16日晚间，CRO（医药研发外包服务）头部企业昭衍新药（603127.SH）披露股东“清仓式”减持计划，引发市场剧烈震荡。3月17日公司A股股价跌停、H股下跌超11%，公司随后迅速发布更正公告，下调减持比例并优化减持方式。对此，《经济参考报》记者致电昭衍新药，尝试了解公司发布更正公告下调股东减持比例是否受到股价下跌的影响，昭衍新药方面表示：“确实有这方面的考虑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603183676233241.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1576","603127","06127","BK1141","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620344094","title":"3月17日昭衍新药（603127）龙虎榜数据：机构净卖出2.02亿元，北向资金净卖出269.05万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2620344094","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620344094?lang=zh_cn&edition=full","pubTime":"2026-03-17 17:17","pubTimestamp":1773739021,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年3月17日公布的交易公开信息显示，昭衍新药因有价格涨跌幅限制的日收盘价格跌幅偏离值达到7%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年3月17日收盘，昭衍新药报收于29.32元，下跌10.01%，换手率4.57%，成交量28.83万手，成交额8.55亿元。从龙虎榜公布的当日买卖数据来看，机构合计净卖出2.02亿元，北向资金合计净卖出269.05万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031700029659.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06127","BK0216","BK1141","603127","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620024446","title":"昭衍新药遭股东“清仓式”减持 业绩预增超两倍为何还留不住人？","url":"https://stock-news.laohu8.com/highlight/detail?id=2620024446","media":"21世纪经济报道","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620024446?lang=zh_cn&edition=full","pubTime":"2026-03-17 15:01","pubTimestamp":1773730898,"startTime":"0","endTime":"0","summary":"3月17日，对于CRO（医药研发外包服务）龙头昭衍新药（603127.SH，06127.HK）的投资者而言，是一个颇不平静的交易日。继前一日发布股东减持计划公告后，昭衍新药今日开盘即跳空低开，盘中一度重挫逾9%，截至发稿时股价仍徘徊在底部区域，市场恐慌情绪可见一斑。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603173674511327.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603173674511327.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0216","BK1141","603127","06127","BK1576"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.2579},{"period":"1month","weight":0.1577},{"period":"3month","weight":0.0631},{"period":"6month","weight":-0.0619},{"period":"1year","weight":0.6927},{"period":"ytd","weight":0.0301}],"compareEarnings":[{"period":"1week","weight":0.0105},{"period":"1month","weight":-0.0253},{"period":"3month","weight":-0.0464},{"period":"6month","weight":-0.0746},{"period":"1year","weight":0.0825},{"period":"ytd","weight":-0.0201}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京昭衍新药研究中心股份有限公司是一家主要从事新药药理毒理学研究的中国公司。该公司通过三个分部开展业务。药物非临床研究服务分部主要提供药品非临床安全性评价服务、药效学研究服务、药代动力学研究服务。临床服务及其他分部主要提供药品上市前的临床服务以及药物警戒服务。实验模型供应分部为实验模型及其附属产品的生产和销售。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.052832},{"month":2,"riseRate":0.6,"avgChangeRate":0.086342},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.020364},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.07799},{"month":5,"riseRate":0.8,"avgChangeRate":0.111301},{"month":6,"riseRate":0.6,"avgChangeRate":0.067356},{"month":7,"riseRate":0.8,"avgChangeRate":0.10434},{"month":8,"riseRate":0,"avgChangeRate":-0.152531},{"month":9,"riseRate":0.6,"avgChangeRate":0.016217},{"month":10,"riseRate":0.2,"avgChangeRate":-0.062992},{"month":11,"riseRate":0.4,"avgChangeRate":0.019594},{"month":12,"riseRate":0.6,"avgChangeRate":0.001916}],"exchange":"SEHK","name":"昭衍新药","nameEN":"JOINN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昭衍新药(06127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昭衍新药,06127,昭衍新药股票,昭衍新药股票老虎,昭衍新药股票老虎国际,昭衍新药行情,昭衍新药股票行情,昭衍新药股价,昭衍新药股市,昭衍新药股票价格,昭衍新药股票交易,昭衍新药股票购买,昭衍新药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昭衍新药(06127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}